7101 - 7150 of 8571 Results
Title
Year
- A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation Outcomes2020RESTRICTEDTitle: A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation OutcomesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 741End Page: 751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28045Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556988Citation Count: 41
-
RESTRICTEDTitle: Inclusion and exclusion criteria for DBS in dystoniaJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23482Best OA location URL: https://europepmc.org/articles/pmc8478120?pdf=renderCitation Count: 88
- Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation2020RESTRICTEDTitle: Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and InflammationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 25End Page: 36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28411Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285924Citation Count: 76
-
RESTRICTEDTitle: A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s DiseaseJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 11Issue #: 4Start Page: 395End Page: 409Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152712800792785Best OA location URL: https://europepmc.org/articles/pmc4978221?pdf=renderCitation Count: 116
- Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases2016RESTRICTEDTitle: Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's DiseasesJournal Name: Cold Spring Harbor Perspectives in BiologyPublisher: Cold Spring Harbor LaboratoryVol: 8Issue #: 11Start Page: a023630End Page: a023630Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1101/cshperspect.a023630Best OA location URL: http://cshperspectives.cshlp.org/content/8/11/a023630.full.pdfCitation Count: 102
-
RESTRICTEDTitle: Phosphoregulation on mitochondria: Integration of cell and organelle responsesJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 25Issue #: 7Start Page: 837End Page: 858Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/cns.13141Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.13141Citation Count: 41
-
RESTRICTEDTitle: Genomewide association study for onset age in Parkinson diseaseJournal Name: BMC Medical GeneticsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2350-10-98Best OA location URL: https://bmcmedgenet.biomedcentral.com/counter/pdf/10.1186/1471-2350-10-98Citation Count: 107
-
RESTRICTEDTitle: The Role of Rab Proteins in Parkinson’s Disease SynaptopathyJournal Name: BiomedicinesPublisher: MDPI AGVol: 10Issue #: 8Start Page: 1941End Page: 1941Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines10081941Best OA location URL: https://www.mdpi.com/2227-9059/10/8/1941/pdf?version=1660634425Citation Count: 15
-
RESTRICTEDTitle: Consensus Paper: Experimental Neurostimulation of the CerebellumJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 6Start Page: 1064End Page: 1097Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-019-01041-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-019-01041-5.pdfCitation Count: 126
-
RESTRICTEDTitle: LRRK2 and Lipid Pathways: Implications for Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 11Start Page: 1597End Page: 1597Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12111597Best OA location URL: https://www.mdpi.com/2218-273X/12/11/1597/pdf?version=1667112107Citation Count: 8
-
RESTRICTEDTitle: The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 10Issue #: 6Start Page: 912End Page: 912Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom10060912Best OA location URL: https://www.mdpi.com/2218-273X/10/6/912/pdf?version=1593094633Citation Count: 21
-
RESTRICTEDTitle: Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes NeurotoxicJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 60Issue #: 17Start Page: 9215End Page: 9246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/anie.202000451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202000451Citation Count: 87
-
RESTRICTEDTitle: The role of the basal ganglia in learning and memory: Insight from Parkinson’s diseaseJournal Name: Neurobiology of Learning and MemoryPublisher: Elsevier BVVol: 96Issue #: 4Start Page: 624End Page: 636Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nlm.2011.08.006Best OA location URL: https://europepmc.org/articles/pmc3772079?pdf=renderCitation Count: 157
- Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms2022RESTRICTEDTitle: Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanismsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 163Issue #:Start Page: 105580End Page: 105580Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105580Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105580Citation Count: 21
-
RESTRICTEDTitle: Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 146Issue #:Start Page: 105088End Page: 105088Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105088Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105088Citation Count: 4
-
RESTRICTEDTitle: Chipping away at diagnostics for neurodegenerative diseasesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 35Issue #: 2Start Page: 148End Page: 156Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2009.02.016Best OA location URL: https://europepmc.org/articles/pmc2753504?pdf=renderCitation Count: 20
- Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models2013RESTRICTEDTitle: Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian modelsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 57Issue #:Start Page: 38End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.06.025Best OA location URL: https://europepmc.org/articles/pmc3815566?pdf=renderCitation Count: 152
-
RESTRICTEDTitle: No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 74Issue #:Start Page: 236.e1End Page: 236.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.022Best OA location URL: http://manuscript.elsevier.com/S0197458018303476/pdf/S0197458018303476.pdfCitation Count: 1
-
RESTRICTEDTitle: Proteostasis control by the unfolded protein responseJournal Name: Nature Cell BiologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 7Start Page: 829End Page: 838Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ncb3184Best OA location URL: https://europepmc.org/articles/pmc5546321?pdf=renderCitation Count: 590
-
RESTRICTEDTitle: The best medicine? The influence of physical activity and inactivity on Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1444End Page: 1454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491025Citation Count: 97
-
RESTRICTEDTitle: Prospects of Statins in Parkinson DiseaseJournal Name: The NeuroscientistPublisher: SAGE PublicationsVol: 17Issue #: 3Start Page: 244End Page: 255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1073858410385006Best OA location URL: https://europepmc.org/articles/pmc3132406?pdf=renderCitation Count: 86
-
RESTRICTEDTitle: α-Synuclein and Mitochondria: Partners in Crime?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 3Start Page: 391End Page: 399Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0182-9Best OA location URL: https://europepmc.org/articles/pmc3701775?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: Intrabodies as Neuroprotective TherapeuticsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 3Start Page: 447End Page: 458Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0193-6Best OA location URL: https://europepmc.org/articles/pmc3701772?pdf=renderCitation Count: 32
-
RESTRICTEDTitle: Multiplexed Profiling of Extracellular Vesicles for Biomarker DevelopmentJournal Name: Nano-Micro LettersPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40820-021-00753-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40820-021-00753-w.pdfCitation Count: 42
- Epigenetic Landscape of Parkinson’s Disease: Emerging Role in Disease Mechanisms and Therapeutic Modalities2013RESTRICTEDTitle: Epigenetic Landscape of Parkinson’s Disease: Emerging Role in Disease Mechanisms and Therapeutic ModalitiesJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 698End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0211-8Best OA location URL: https://europepmc.org/articles/pmc3805874?pdf=renderCitation Count: 73
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 78
-
RESTRICTEDTitle: Urate as a Marker of Risk and Progression of Neurodegenerative DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 148End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0497-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0497-4.pdfCitation Count: 74
-
RESTRICTEDTitle: The Nuclear Envelope: An Intriguing Focal Point for Neurogenetic DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 764End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0296-8Best OA location URL: https://europepmc.org/articles/pmc4391386?pdf=renderCitation Count: 17
- Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s Disease2016RESTRICTEDTitle: Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 3Start Page: 635End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0449-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0449-z.pdfCitation Count: 17
-
RESTRICTEDTitle: Approach to Cognitive Impairment in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1495End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00963-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00963-x.pdfCitation Count: 38
-
RESTRICTEDTitle: Emerging Targeted Therapeutics for Genetic Subtypes of ParkinsonismJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1378End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00920-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00920-8.pdfCitation Count: 27
-
RESTRICTEDTitle: Nucleic Acid–Based Therapeutics for Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 45
- Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention2020RESTRICTEDTitle: Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and RetentionJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1724End Page: 1735Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00960-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00960-0.pdfCitation Count: 37
-
RESTRICTEDTitle: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1539End Page: 1562Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00940-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00940-4.pdfCitation Count: 23
- Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments2020RESTRICTEDTitle: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1681End Page: 1693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00914-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00914-6.pdfCitation Count: 58
-
RESTRICTEDTitle: Manganism in the 21st century: The Hanninen lectureJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 45Issue #:Start Page: 201End Page: 207Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2013.09.007Best OA location URL: https://europepmc.org/articles/pmc3992192?pdf=renderCitation Count: 65
-
RESTRICTEDTitle: Cell therapy in Parkinson’s diseaseJournal Name: NeuroRXPublisher: Springer Science and Business Media LLCVol: 1Issue #: 4Start Page: 382End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1602/neurorx.1.4.382Best OA location URL: https://link.springer.com/content/pdf/10.1602%2Fneurorx.1.4.382.pdfCitation Count: 334
- Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease2019RESTRICTEDTitle: Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s diseaseJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 103Issue #:Start Page: 305End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.neubiorev.2019.05.016Best OA location URL: http://manuscript.elsevier.com/S0149763419300284/pdf/S0149763419300284.pdfCitation Count: 95
- The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?2020RESTRICTEDTitle: The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?Journal Name: The NeuroscientistPublisher: SAGE PublicationsVol: 26Issue #: 5-6Start Page: 503End Page: 520Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1073858420916696Best OA location URL: https://europepmc.org/articles/pmc8447404?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Finding useful biomarkers for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 454Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aam6003Best OA location URL: https://europepmc.org/articles/pmc6097233?pdf=renderCitation Count: 119
-
RESTRICTEDTitle: Alpha-synuclein oligomers: a new hopeJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 134Issue #: 6Start Page: 819End Page: 838Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1755-1Best OA location URL: https://europepmc.org/articles/pmc5663814?pdf=renderCitation Count: 255
- Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies2018RESTRICTEDTitle: Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 3Start Page: 363End Page: 377Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-018-1941-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-018-1941-9.pdfCitation Count: 6
-
RESTRICTEDTitle: Selective vulnerability in α-synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 138Issue #: 5Start Page: 681End Page: 704Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-02010-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-02010-2.pdfCitation Count: 59
-
RESTRICTEDTitle: Periphery and brain, innate and adaptive immunity in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 4Start Page: 527End Page: 545Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02268-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02268-5.pdfCitation Count: 147
-
RESTRICTEDTitle: Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challengesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 145Issue #: 5Start Page: 515End Page: 540Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02557-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02557-1.pdfCitation Count: 22
-
RESTRICTEDTitle: Epigenetic regulation in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 132Issue #: 4Start Page: 515End Page: 530Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-016-1590-9Best OA location URL: https://europepmc.org/articles/pmc5026906?pdf=renderCitation Count: 84
-
RESTRICTEDTitle: Neuroimaging of Freezing of GaitJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 5Issue #: 2Start Page: 241End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-150536Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150536?id=journal-of-parkinsons-disease%2Fjpd150536Citation Count: 90
- Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease Project2023RESTRICTEDTitle: Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease ProjectJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 10Start Page: e0292180End Page: e0292180Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0292180Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292180&type=printableCitation Count: 0
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease2014RESTRICTEDTitle: Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 46Issue #: 9Start Page: 989End Page: 993Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ng.3043Best OA location URL: https://pure.mpg.de/pubman/item/item_2129586_1/component/file_2129585/Nalls.pdfCitation Count: 1696
-
RESTRICTEDTitle: Is Axonal Degeneration a Key Early Event in Parkinson’s Disease?Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 6Issue #: 4Start Page: 703End Page: 707Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-160881Best OA location URL: http://darchive.mblwhoilibrary.org/bitstreams/2010ffba-e9af-51c2-a5bd-d7afa7449372/downloadCitation Count: 39